Disodium 2'-deoxy-5'-O-phosphonatocytidine(CAS: 13085-50-2)

Disodium 2'-deoxy-5'-O-phosphonatocytidine (CAS: 13085-50-2) must comply with global regulations such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH in the European Union, and FDA and EPA requirements in the United States. Specifically, it needs to be classified according to its physical, health, and environmental hazards. Compliance with these guidelines ensures safe handling, storage, and transportation.

There are several alternatives to Disodium 2'-deoxy-5'-O-phosphonatocytidine (CAS: 13085-50-2) in synthesis, including 2'-deoxy-5'-O-phosphonatocytidine and its analogs. Common alternative reagents include phosphorus oxychloride and other nucleoside phosphonates. These alternatives can offer similar functionalities or serve as intermediates in different pathways, depending on the specific application.

The market and research trend for Disodium 2'-deoxy-5'-O-phosphonatocytidine (CAS: 13085-50-2) is driven by its potential in antiviral and anticancer treatments. Recent studies focus on its application in nucleotide analogs for targeted therapy. The demand is expected to grow with advancements in medical research and development of new therapeutic strategies.

Waste containing Disodium 2'-deoxy-5'-O-phosphonatocytidine (CAS: 13085-50-2) should be collected in appropriate containers and disposed of in accordance with local and international hazardous waste regulations. Incineration or professional waste disposal services may be necessary. Proper handling and disposal methods are crucial to prevent environmental contamination and ensure safety.